News
$eFFECTOR Therapeutics(EFTR.US$ EFFECTOR Receives FDA Fast Track Designation For Zotatifin In Combination With Fulvestrant And Abemaciclib For ER+/HER2- Advanced Metastatic Breast Cancer![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Jason GKS : 50％up？
TrytosaveabitOP Jason GKS: Not sure? This one acts strange when it does get a good PR? But I’m hoping for at least 25%. GL
JESSE JAMES8832 : should be moon news but can never tell